|
1
|
Rogers JE, Sewastjanow-Silva M, Waters RE
and Ajani JA: Esophageal cancer: Emerging therapeutics. Expert Opin
Ther Targets. 26:107–117. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morgan E, Soerjomataram I, Rumgay H,
Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J and Arnold
M: The global landscape of esophageal squamous cell carcinoma and
esophageal adenocarcinoma incidence and mortality in 2020 and
projections to 2040: New estimates from GLOBOCAN 2020.
Gastroenterology. 163:649–658.e2. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He S, Xu J, Liu X and Zhen Y: Advances and
challenges in the treatment of esophageal cancer. Acta Pharm Sin B.
11:3379–3392. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rumgay H, Arnold M, Laversanne M, Whiteman
DC, Thrift AP, Wei W, Lemmens VEPP and Soerjomataram I:
International trends in esophageal squamous cell carcinoma and
adenocarcinoma incidence. Am J Gastroenterol. 116:1072–1076. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Xu J, Zheng Y, Gao Y, He S, Li H,
Zou K, Li N, Tian J, Chen W and He J: Esophageal cancer:
Epidemiology, risk factors and screening. Chin J Cancer Res.
33:535–547. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhat AA, Nisar S, Maacha S, Carneiro-Lobo
TC, Akhtar S, Siveen KS, Wani NA, Rizwan A, Bagga P, Singh M, et
al: Cytokine-chemokine network driven metastasis in esophageal
cancer; promising avenue for targeted therapy. Mol Cancer.
20:22021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang FL and Yu SJ: Esophageal cancer:
Risk factors, genetic association, and treatment. Asian J Surg.
41:210–215. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Liu X, Lin C, Jia X, Zhu H, Song J
and Zhang Y: Noncoding RNAs regulate alternative splicing in
cancer. J Exp Clin Cancer Res. 40:112021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mohapatra S, Pioppini C, Ozpolat B and
Calin GA: Non-coding RNAs regulation of macrophage polarization in
cancer. Mol Cancer. 20:242021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poller W, Sahoo S, Hajjar R, Landmesser U
and Krichevsky AM: Exploration of the noncoding genome for
human-specific therapeutic targets-recent insights at molecular and
cellular level. Cells. 12:26602023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou B, Yang H, Yang C, Bao YL, Yang SM,
Liu J and Xiao YF: Translation of noncoding RNAs and cancer. Cancer
Lett. 497:89–99. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Slack FJ and Chinnaiyan AM: The role of
non-coding RNAs in oncology. Cell. 179:1033–1055. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ran H, Yang Y, Luo M, Liu X, Yue B, Chai
Z, Zhong J and Wang H: Molecular regulation of yak preadipocyte
differentiation and proliferation by LncFAM200B and ceRNA
regulatory network analysis. Cells. 11:23662022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Min X, Cai MY, Shao T, Xu ZY, Liao Z, Liu
DL, Zhou MY, Wu WP, Zhou YL, Mo MH, et al: A circular intronic RNA
ciPVT1 delays endothelial cell senescence by regulating the
miR-24-3p/CDK4/pRb axis. Aging Cell. 21:e135292022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qu J, Xiong X, Hujie G, Ren J, Yan L and
Ma L: MicroRNA-132-3p alleviates neuron apoptosis and impairments
of learning and memory abilities in Alzheimer's disease by
downregulation of HNRNPU stabilized BACE1. Cell Cycle.
20:2309–2320. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu CX, Guo SK, Nan F, Xu YF, Yang L and
Chen LL: RNA circles with minimized immunogenicity as potent PKR
inhibitors. Mol Cell. 82:420–434.e6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng Q, Zhang H, Yao D, Chen WD and Wang
YD: Emerging role of non-coding RNAs in esophageal squamous cell
carcinoma. Int J Mol Sci. 21:2582019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyoshi J, Zhu Z, Luo A, Toden S, Zhou X,
Izumi D, Kanda M, Takayama T, Parker IM, Wang M, et al: A
microRNA-based liquid biopsy signature for the early detection of
esophageal squamous cell carcinoma: A retrospective, prospective
and multicenter study. Mol Cancer. 21:442022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sharma U, Murmu M, Barwal TS, Tuli HS,
Jain M, Prakash H, Kaceli T, Jain A and Bishayee A: A pleiotropic
role of long non-coding RNAs in the modulation of Wnt/β-catenin and
PI3K/Akt/mTOR signaling pathways in esophageal squamous cell
carcinoma: Implication in chemotherapeutic drug response. Curr
Oncol. 29:2326–2349. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang C, Liu WR, Tan S, Zhou JK, Xu X, Ming
Y, Cheng J, Li J, Zeng Z, Zuo Y, et al: Characterization of
distinct circular RNA signatures in solid tumors. Mol Cancer.
21:632022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Acunzo M and Croce CM: MicroRNA in cancer
and cachexia-a mini-review. J Infect Dis. 212 (Suppl 1):S74–S77.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mengistu AA and Tenkegna TA: The role of
miRNA in plant-virus interaction: A review. Mol Biol Rep.
48:2853–2861. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wahid F, Shehzad A, Khan T and Kim YY:
MicroRNAs: Synthesis, mechanism, function, and recent clinical
trials. Biochim Biophys Acta. 1803:1231–1243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Budakoti M, Panwar AS, Molpa D, Singh RK,
Büsselberg D, Mishra AP, Coutinho HDM and Nigam M: Micro-RNA: The
darkhorse of cancer. Cell Signal. 83:1099952021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wilson RC, Tambe A, Kidwell MA, Noland CL,
Schneider CP and Doudna JA: Dicer-TRBP complex formation ensures
accurate mammalian microRNA biogenesis. Mol Cell. 57:397–407. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi
S, Xie H, Peng X, Yin W, Tao Y and Wang X: miRNA-based biomarkers,
therapies, and resistance in cancer. Int J Biol Sci. 16:2628–2647.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ho PTB, Clark IM and Le LTT:
MicroRNA-based diagnosis and therapy. Int J Mol Sci. 23:71972022.
View Article : Google Scholar
|
|
34
|
Iqbal MA, Arora S, Prakasam G, Calin GA
and Syed MA: MicroRNA in lung cancer: Role, mechanisms, pathways
and therapeutic relevance. Mol Aspects Med. 70:3–20. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
O'Brien J, Hayder H, Zayed Y and Peng C:
Overview of MicroRNA biogenesis, mechanisms of actions, and
circulation. Front Endocrinol (Lausanne). 9:4022018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Medley JC, Panzade G and Zinovyeva AY:
microRNA strand selection: Unwinding the rules. Wiley Interdiscip
Rev RNA. 12:e16272021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bartel DP: Metazoan MicroRNAs. Cell.
173:20–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Q, Hao Q and Prasanth KV: Nuclear long
noncoding RNAs: Key regulators of gene expression. Trends Genet.
34:142–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao Q, Guo Z, Yan Y, Wu J and Song C:
Exosomal long noncoding RNAs in aging and age-related diseases.
IUBMB Life. 71:1846–1856. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kour S and Rath PC: Long noncoding RNAs in
aging and age-related diseases. Ageing Res Rev. 26:1–21. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He Z, Yang D, Fan X, Zhang M, Li Y, Gu X
and Yang M: The roles and mechanisms of lncRNAs in liver fibrosis.
Int J Mol Sci. 21:14822020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Aboudehen K: Regulation of mTOR signaling
by long non-coding RNA. Biochim Biophys Acta Gene Regul Mech.
1863:1944492020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jain AK, Xi Y, McCarthy R, Allton K,
Akdemir KC, Patel LR, Aronow B, Lin C, Li W, Yang L, et al:
LncPRESS1 Is a p53-regulated LncRNA that safeguards pluripotency by
disrupting SIRT6-mediated de-acetylation of histone H3K56. Mol
Cell. 64:967–981. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Du Z, Wen X, Wang Y, Jia L, Zhang S, Liu
Y, Zhou L, Li H, Yang W, Wang C, et al: Chromatin lncRNA Platr10
controls stem cell pluripotency by coordinating an intrachromosomal
regulatory network. Genome Biol. 22:2332021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang Y, Huang YX, Wang DL, Yang B, Yan
HY, Lin LH, Li Y, Chen J, Xie LM, Huang YS, et al: LncRNA DSCAM-AS1
interacts with YBX1 to promote cancer progression by forming a
positive feedback loop that activates FOXA1 transcription network.
Theranostics. 10:10823–10837. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Su K, Wang N, Shao Q, Liu H, Zhao B and Ma
S: The role of a ceRNA regulatory network based on lncRNA MALAT1
site in cancer progression. Biomed Pharmacother. 137:1113892021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang W, Sun YM, Pan Q, Fang K, Chen XT,
Zeng ZC, Chen TQ, Zhu SX, Huang LB, Luo XQ, et al: The snoRNA-like
lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing
enzyme ADAR1. Cell Discov. 8:1172022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang X, Ye T, Liu H, Lv P, Duan C, Wu X,
Jiang K, Lu H, Xia D, Peng E, et al: Expression profiles,
biological functions and clinical significance of circRNAs in
bladder cancer. Mol Cancer. 20:42021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hu Q and Zhou T: EIciRNA-mediated gene
expression: Tunability and bimodality. FEBS Lett. 592:3460–3471.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhou X and Du J: CircRNAs: Novel
therapeutic targets in multiple myeloma. Mol Biol Rep.
49:10667–10676. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vahabi A, Rezaie J, Hassanpour M, Panahi Y
and Nemati M, Rasmi Y and Nemati M: Tumor cells-derived exosomal
CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical
opportunities. Biochem Pharmacol. 200:1150382022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Amicone L, Marchetti A and Cicchini C:
Exosome-associated circRNAs as key regulators of EMT in cancer.
Cells. 11:17162022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guo X, Chang X, Wang Z, Jiang C and Wei Z:
CircRNAs: Promising factors for regulating angiogenesis in
colorectal cancer. Clin Transl Oncol. 24:1673–1681. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li X, Yang L and Chen LL: The biogenesis,
functions, and challenges of circular RNAs. Mol Cell. 71:428–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang LX, Gao J, Long X, Zhang PF, Yang X,
Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, et al: The circular RNA
circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung
adenocarcinomas and squamous cell carcinomas via the
miR-181a-5p/CARM1 axis. Mol Cancer. 21:1102022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hollensen AK, Thomsen HS, Lloret-Llinares
M, Kamstrup AB, Jensen JM, Luckmann M, Birkmose N, Palmfeldt J,
Jensen TH, Hansen TB and Damgaard CK: circZNF827 nucleates a
transcription inhibitory complex to balance neuronal
differentiation. Elife. 9:e584782020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Misir S, Wu N and Yang BB: Specific
expression and functions of circular RNAs. Cell Death Differ.
29:481–491. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang X, Ma R, Zhang X, Cui L, Ding Y, Shi
W, Guo C and Shi Y: Crosstalk between N6-methyladenosine
modification and circular RNAs: Current understanding and future
directions. Mol Cancer. 20:1212021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lin H, Wang Y, Wang P, Long F and Wang T:
Mutual regulation between N6-methyladenosine (m6A) modification and
circular RNAs in cancer: Impacts on therapeutic resistance. Mol
Cancer. 21:1482022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Meyer KD, Patil DP, Zhou J, Zinoviev A,
Skabkin MA, Elemento O, Pestova TV, Qian SB and Jaffrey SR: 5′ UTR
m(6)A promotes cap-independent translation. Cell. 163:999–1010.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Li R, Jiang J, Shi H, Qian H, Zhang X and
Xu W: CircRNA: A rising star in gastric cancer. Cell Mol Life Sci.
77:1661–1680. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yang Y, Fan X, Mao M, Song X, Wu P, Zhang
Y, Jin Y, Yang Y, Chen LL, Wang Y, et al: Extensive translation of
circular RNAs driven by N6-methyladenosine. Cell Res.
27:626–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Duan JL, Chen W, Xie JJ, Zhang ML, Nie RC,
Liang H, Mei J, Han K, Xiang ZC, Wang FW, et al: A novel peptide
encoded by N6-methyladenosine modified circMAP3K4 prevents
apoptosis in hepatocellular carcinoma. Mol Cancer. 21:932022.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
cancer. Mol Cancer. 19:302020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yu XM, Li SJ, Yao ZT, Xu JJ, Zheng CC, Liu
ZC, Ding PB, Jiang ZL, Wei X, Zhao LP, et al: N4-acetylcytidine
modification of lncRNA CTC-490G23.2 promotes cancer metastasis
through interacting with PTBP1 to increase CD44 alternative
splicing. Oncogene. 42:1101–1116. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Huang X, Liu C, Li H, Dai T, Luo G, Zhang
C, Li T and Lü M: Hypoxia-responsive lncRNA G077640 promotes ESCC
tumorigenesis via the H2AX-HIF1α-glycolysis axis. Carcinogenesis.
44:383–393. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Xiao Z, Feng X, Zhou Y, Li P, Luo J, Zhang
W, Zhou J, Zhao J, Wang D, Wang Y, et al: Exosomal miR-10527-5p
inhibits migration, invasion, lymphangiogenesis and lymphatic
metastasis by affecting Wnt/β-catenin signaling via Rab10 in
esophageal squamous cell carcinoma. Int J Nanomedicine. 18:95–114.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Cui Y, Zhang C, Ma S, Li Z, Wang W, Li Y,
Ma Y, Fang J, Wang Y, Cao W and Guan F: RNA m6A demethylase
FTO-mediated epigenetic up-regulation of LINC00022 promotes
tumorigenesis in esophageal squamous cell carcinoma. J Exp Clin
Cancer Res. 40:2942021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ren K, Li Y, Lu H, Li Z, Li Z, Wu K, Li Z
and Han X: Long noncoding RNA HOTAIR controls cell cycle by
functioning as a competing endogenous RNA in esophageal squamous
cell carcinoma. Transl Oncol. 9:489–497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Xu T, Hu Y, Zhao Y, Qi Y, Zhang S and Li
P: Hsa_circ_0046534 accelerates esophageal squamous cell carcinoma
proliferation and metastasis via regulating MMP2 expression by
sponging miR-339-5p. Cell Signal. 112:1109062023. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Xian D, Yang S, Liu Y, Liu Q, Huang D and
Wu Y: MicroRNA-196a-5p facilitates the onset and progression via
targeting ITM2B in esophageal squamous cell carcinoma. Pathol Int.
74:129–138. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhang Y, Dong X, Guo X, Li C, Fan Y, Liu
P, Yuan D, Ma X, Wang J, Zheng J, et al: LncRNA-BC069792 suppresses
tumor progression by targeting KCNQ4 in breast cancer. Mol Cancer.
22:412023. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu QL, Zhang Z, Wei X and Zhou ZG:
Noncoding RNAs in tumor metastasis: Molecular and clinical
perspectives. Cell Mol Life Sci. 78:6823–6850. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Enkhnaran B, Zhang GC, Zhang NP, Liu HN,
Wu H, Xuan S, Yu XN, Song GQ, Shen XZ, Zhu JM, et al:
microRNA-106b-5p promotes cell growth and sensitizes
chemosensitivity to sorafenib by targeting the BTG3/Bcl-xL/p27
signaling pathway in hepatocellular carcinoma. J Oncol.
2022:19715592022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang H, Peng D, Gan M, He Z and Kuang Y:
CPEB3 overexpression caused by miR-106b-5p inhibition inhibits
esophageal carcinoma in-vitro progression and metastasis.
Anticancer Drugs. 33:335–351. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yang F, Sun Z, Wang D and Du T:
MiR-106b-5p regulates esophageal squamous cell carcinoma
progression by binding to HPGD. BMC Cancer. 22:3082022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Deng W, Fan W, Li P, Yao J, Qi J, Chi H,
Ji G and Zhao J: microRNA-497-mediated Smurf2/YY1/HIF2α axis in
tumor growth and metastasis of esophageal squamous cell carcinoma.
J Biochem Mol Toxicol. 36:e231822022. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
He Z, Chen J, Chen X, Wang H, Tang L and
Han C: microRNA-377 acts as a suppressor in esophageal squamous
cell carcinoma through CBX3-dependent P53/P21 pathway. J Cell
Physiol. 236:107–120. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ren L, Fang X, Shrestha SM, Ji Q, Ye H,
Liang Y, Liu Y, Feng Y, Dong J and Shi R: LncRNA SNHG16 promotes
development of oesophageal squamous cell carcinoma by interacting
with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett.
27:892022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yang X, Zeng T, Liu Z, He W, Hu M, Tang T,
Chen L and Xing L: Long noncoding RNA GK-IT1 promotes esophageal
squamous cell carcinoma by regulating MAPK1 phosphorylation. Cancer
Med. 11:4555–4574. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Xue ST, Zheng B, Cao SQ, Ding JC, Hu GS,
Liu W and Chen C: Long non-coding RNA LINC00680 functions as a
ceRNA to promote esophageal squamous cell carcinoma progression
through the miR-423-5p/PAK6 axis. Mol Cancer. 21:692022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Xiong G, Diao D, Lu D, Liu X, Liu Z, Mai
S, Feng S, Dong X and Cai K: Circular RNA circNELL2 acts as the
sponge of miR-127-5p to promote esophageal squamous cell carcinoma
progression. Onco Targets Ther. 13:9245–9255. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Li Z, Qin X, Bian W, Li Y, Shan B, Yao Z
and Li S: Exosomal lncRNA ZFAS1 regulates esophageal squamous cell
carcinoma cell proliferation, invasion, migration and apoptosis via
microRNA-124/STAT3 axis. J Exp Clin Cancer Res. 38:4772019.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tian Z, Li Z, Zhu Y, Meng L, Liu F, Sang M
and Wang G: Hypermethylation-mediated inactivation of miR-124
predicts poor prognosis and promotes tumor growth at least
partially through targeting EZH2/H3K27me3 in ESCC. Clin Exp
Metastasis. 36:381–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zeng B, Liu Z, Zhu H, Zhang X, Yang W, Li
X and Cheng C: CircRNA_2646 functions as a ceRNA to promote
progression of esophageal squamous cell carcinoma via inhibiting
miR-124/PLP2 signaling pathway. Cell Death Discov. 7:992021.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yao D, Lin S, Chen S and Wang Z: circHIPK3
regulates cell proliferation and migration by sponging microRNA-124
and regulating serine/threonine kinase 3 expression in esophageal
squamous cell carcinoma. Bioengineered. 13:9767–9780. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Cheng J, Ma H, Yan M, Zhang Z and Xing W:
Circ_0007624 suppresses the development of esophageal squamous cell
carcinoma via targeting miR-224-5p/CPEB3 to inactivate the
EGFR/PI3K/AKT signaling. Cell Signal. 99:1104482022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chen Z, Yao N, Gu H, Song Y, Ye Z, Li L,
Lu P and Shao Q: Circular RNA_LARP4 sponges miR-1323 and hampers
progression of esophageal squamous cell carcinoma through
modulating PTEN/PI3K/AKT pathway. Dig Dis Sci. 65:2272–2283. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Jiang Q, Wang H, Yuan D, Qian X, Ma X, Yan
M and Xing W: Circular_0086414 induces SPARC like 1 (SPARCL1)
production to inhibit esophageal cancer cell proliferation,
invasion and glycolysis and induce cell apoptosis by sponging
miR-1290. Bioengineered. 13:12099–12114. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zheng S, Liu B and Guan X: The role of
tumor microenvironment in invasion and metastasis of esophageal
squamous cell carcinoma. Front Oncol. 12:9112852022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wang X, Han J, Liu Y, Hu J, Li M, Chen X
and Xu L: miR-17-5p and miR-4443 promote esophageal squamous cell
carcinoma development by targeting TIMP2. Front Oncol.
11:6058942021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Liang Y, Duan L, Lu J and Xia J:
Engineering exosomes for targeted drug delivery. Theranostics.
11:3183–3195. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Paskeh MDA, Entezari M, Mirzaei S,
Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M,
Hushmandi K, et al: Emerging role of exosomes in cancer progression
and tumor microenvironment remodeling. J Hematol Oncol. 15:832022.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Liu T, Li P, Li J, Qi Q, Sun Z, Shi S, Xie
Y, Liu S, Wang Y, Du L and Wang C: Exosomal and intracellular
miR-320b promotes lymphatic metastasis in esophageal squamous cell
carcinoma. Mol Ther Oncolytics. 23:163–180. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Cui D, Zhu Y, Yan D, Lee NPY, Han L, Law
S, Tsao GSW and Cheung ALM: Dual inhibition of cMET and EGFR by
microRNA-338-5p suppresses metastasis of esophageal squamous cell
carcinoma. Carcinogenesis. 42:995–1007. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhao R, Shan Y, Zhou X, Zhang C, Zhao R,
Zhao L and Shan B: MicroRNA-485-5p suppresses the progression of
esophageal squamous cell carcinoma by targeting flotillin-1 and
inhibits the epithelial-mesenchymal transition. Oncol Rep.
45:932021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Cheng W, Yang F and Ma Y: lncRNA TPT1-AS1
promotes cell migration and invasion in esophageal squamous-cell
carcinomas by regulating the miR-26a/HMGA1 axis. Open Med (Wars).
18:202205332023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yang R, Wan J, Ma L, Zhou F, Yang Z, Li Z,
Zhang M and Ming L: TMEM44-AS1 promotes esophageal squamous cell
carcinoma progression by regulating the IGF2BP2-GPX4 axis in
modulating ferroptosis. Cell Death Discov. 9:4312023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wang J, Huang TJ, Mei Y, Luo FF, Xie DH,
Peng LX, Liu BQ, Fan ML, Zhang JB, Zheng ST, et al: Novel long
noncoding RNA LINC02820 augments TNF signaling pathway to remodel
cytoskeleton and potentiate metastasis in esophageal squamous cell
carcinoma. Cancer Gene Ther. 30:375–387. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Li H, Lin PH, Gupta P, Li X, Zhao SL, Zhou
X, Li Z, Wei S, Xu L, Han R, et al: MG53 suppresses tumor
progression and stress granule formation by modulating G3BP2
activity in non-small cell lung cancer. Mol Cancer. 20:1182021.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhang Y, Yue C, Krichevsky AM and
Garkavtsev I: Repression of the stress granule protein G3BP2
inhibits immune checkpoint molecule PD-L1. Mol Oncol. Feb
1–2021.(Epub ahead of print).
|
|
108
|
Zheng Y, Wu J, Deng R, Lin C, Huang Y,
Yang X, Wang C, Yang M, He Y, Lu J, et al: G3BP2 regulated by the
lncRNA LINC01554 facilitates esophageal squamous cell carcinoma
metastasis through stabilizing HDGF transcript. Oncogene.
41:515–526. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhang H, Wang Y, Zhang W, Wu Q, Fan J and
Zhan Q: BAALC-AS1/G3BP2/c-Myc feedback loop promotes cell
proliferation in esophageal squamous cell carcinoma. Cancer Commun
(Lond). 41:240–257. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wu K, Wang Z, Huang Y, Yao L, Kang N, Ge
W, Zhang R and He W: LncRNA PTPRG-AS1 facilitates glycolysis and
stemness properties of esophageal squamous cell carcinoma cells
through miR-599/PDK1 axis. J Gastroenterol Hepatol. 37:507–517.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Shi Y, Fang N, Li Y, Guo Z, Jiang W, He Y,
Ma Z and Chen Y: Circular RNA LPAR3 sponges microRNA-198 to
facilitate esophageal cancer migration, invasion, and metastasis.
Cancer Sci. 111:2824–2836. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Xu Z, Tie X, Li N, Yi Z, Shen F and Zhang
Y: Circular RNA hsa_circ_0000654 promotes esophageal squamous cell
carcinoma progression by regulating the miR-149-5p/IL-6/STAT3
pathway. IUBMB Life. 72:426–439. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Wang J, Wang Q, Gong Y, Hu Q, Zhang H, Ke
S and Chen Y: Knockdown of circRNA circ_0087378 represses the
tumorigenesis and progression of esophageal squamous cell carcinoma
through modulating the miR-140-3p/E2F3 axis. Front Oncol.
10:6072312021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Brown MS, Muller KE and Pattabiraman DR:
Quantifying the epithelial-to-mesenchymal transition (EMT) from
bench to bedside. Cancers (Basel). 14:11382022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Huang Y, Hong W and Wei X: The molecular
mechanisms and therapeutic strategies of EMT in tumor progression
and metastasis. J Hematol Oncol. 15:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhu C, Bi W, Li H and Wang W: CircLONP2
accelerates esophageal squamous cell carcinoma progression via
direct MiR-27b-3p-ZEB1 axis. Front Oncol. 12:8228392022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chen X, Sun H, Zhao Y, Zhang J, Xiong G,
Cui Y and Lei C: CircRNA circ_0004370 promotes cell proliferation,
migration, and invasion and inhibits cell apoptosis of esophageal
cancer via miR-1301-3p/COL1A1 axis. Open Med (Wars). 16:104–116.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Xu P, Wang L, Liu Q, Gao P, Hu F, Xie X,
Jiang L, Bi R, Ding F, Yang Q and Xiao H: The abnormal expression
of circ-ARAP2 promotes ESCC progression through regulating
miR-761/FOXM1 axis-mediated stemness and the
endothelial-mesenchymal transition. J Transl Med. 20:3182022.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Song B, Liu X, Dong H and Roy R:
miR-140-3P induces chemotherapy resistance in esophageal carcinoma
by targeting the NFYA-MDR1 axis. Appl Biochem Biotechnol.
195:973–991. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Zhao F, Tian H, Wang Y, Zhang J, Liu F and
Fu L: LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated
macrophages induces radioresistance and the formation of
immunosuppressive tumor microenvironment in esophageal squamous
cell carcinoma. Cancer Immunol Immunother. 72:1835–1851. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Wu J, Liu Y, Huang X, Cheng Y, Qian Z, Ni
X, Chen S, Lin M and Luo J: LncRNA DGCR5 silencing enhances the
radio-sensitivity of human esophageal squamous cell carcinoma via
negatively regulating the Warburg effect. Radiat Res. 199:264–272.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zuo J, Zhao M, Fan Z, Liu B, Wang Y, Li Y,
Lv P, Xing L, Zhang X and Shen H: MicroRNA-153-3p regulates cell
proliferation and cisplatin resistance via Nrf-2 in esophageal
squamous cell carcinoma. Thorac Cancer. 11:738–747. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Qiao Y, Zhang C, Li A, Wang D, Luo Z, Ping
Y, Zhou B, Liu S, Li H, Yue D, et al: IL6 derived from
cancer-associated fibroblasts promotes chemoresistance via CXCR7 in
esophageal squamous cell carcinoma. Oncogene. 37:873–883. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Che Y, Wang J, Li Y, Lu Z, Huang J, Sun S,
Mao S, Lei Y, Zang R, Sun N and He L: Cisplatin-activated PAI-1
secretion in the cancer-associated fibroblasts with paracrine
effects promoting esophageal squamous cell carcinoma progression
and causing chemoresistance. Cell Death Dis. 9:7592018. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhuang J, Shen L, Li M, Sun J, Hao J, Li
J, Zhu Z, Ge S, Zhang D, Guo H, et al: Cancer-associated
fibroblast-derived miR-146a-5p generates a niche that promotes
bladder cancer stemness and chemoresistance. Cancer Res.
83:1611–1627. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Kang SH, Oh SY, Lee KY, Lee HJ, Kim MS,
Kwon TG, Kim JW, Lee ST, Choi SY and Hong SH: Differential effect
of cancer-associated fibroblast-derived extracellular vesicles on
cisplatin resistance in oral squamous cell carcinoma via
miR-876-3p. Theranostics. 14:460–479. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zhao Q, Huang L, Qin G, Qiao Y, Ren F,
Shen C, Wang S, Liu S, Lian J, Wang D, et al: Cancer-associated
fibroblasts induce monocytic myeloid-derived suppressor cell
generation via IL-6/exosomal miR-21-activated STAT3 signaling to
promote cisplatin resistance in esophageal squamous cell carcinoma.
Cancer Lett. 518:35–48. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Guo D, Jin J, Liu J, Dong X, Li D and He
Y: MicroRNA-29b regulates the radiosensitivity of esophageal
squamous cell carcinoma by regulating the BTG2-mediated cell cycle.
Strahlenther Onkol. 197:829–835. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wu Q, Zhang H, Yang D, Min Q, Wang Y,
Zhang W and Zhan Q: The m6A-induced lncRNA CASC8 promotes
proliferation and chemoresistance via upregulation of hnRNPL in
esophageal squamous cell carcinoma. Int J Biol Sci. 18:4824–4836.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y,
Cheng Z, Wang X, Wang Y, Liu T, et al: Long non-coding RNA
NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of
esophageal squamous cell carcinoma by promoting nuclear
accumulation of β-catenin. Mol Cancer. 20:1622021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Tong Y, Yang L, Yu C, Zhu W, Zhou X, Xiong
Y, Wang W, Ji F, He D and Cao X: Tumor-secreted exosomal lncRNA
POU3F3 promotes cisplatin resistance in ESCC by inducing fibroblast
differentiation into CAFs. Mol Ther Oncolytics. 18:1–13. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang P, Yang Z, Ye T, Shao F, Li J, Sun N
and He J: lncTUG1/miR-144-3p affect the radiosensitivity of
esophageal squamous cell carcinoma by competitively regulating
c-MET. J Exp Clin Cancer Res. 39:72020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Liu Z, Lu X, Wen L, You C, Jin X and Liu
J: Hsa_circ_0014879 regulates the radiosensitivity of esophageal
squamous cell carcinoma through miR-519-3p/CDC25A axis. Anticancer
Drugs. 33:e349–e361. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Cheng J, Zhang R, Yan M and Li Y: Circular
RNA hsa_circ_0000277 promotes tumor progression and DDP resistance
in esophageal squamous cell carcinoma. BMC Cancer. 22:2382022.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zhou S, Guo Z, Lv X and Zhang X: CircGOT1
promotes cell proliferation, mobility, and glycolysis-mediated
cisplatin resistance via inhibiting its host gene GOT1 in
esophageal squamous cell cancer. Cell Cycle. 21:247–260. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Liu Z, Gu S, Wu K, Li L, Dong C, Wang W
and Zhou Y: CircRNA-DOPEY2 enhances the chemosensitivity of
esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1
translation. J Exp Clin Cancer Res. 40:3612021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Zhu H, Du F and Cao C: Restoration of
circPSMC3 sensitizes gefitinib-resistant esophageal squamous cell
carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis.
Cell Biol Int. 45:107–116. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Tang Q, Zhao S, Zhou N, He J, Zu L, Liu T,
Song Z, Chen J, Peng L and Xu S: PD-1/PD-L1 immune checkpoint
inhibitors in neoadjuvant therapy for solid tumors (review). Int J
Oncol. 62:492023. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Yi M, Zheng X, Niu M, Zhu S, Ge H and Wu
K: Combination strategies with PD-1/PD-L1 blockade: Current
advances and future directions. Mol Cancer. 21:282022. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Jiang W, Pan S, Chen X, Wang ZW and Zhu X:
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in
cancer immunotherapy. Mol Cancer. 20:1162021. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Fang Z, Jiang C and Li S: The potential
regulatory roles of circular RNAs in tumor immunology and
immunotherapy. Front Immunol. 11:6175832021. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Gao C, Xu YJ, Qi L, Bao YF, Zhang L and
Zheng L: CircRNA VIM silence synergizes with sevoflurane to inhibit
immune escape and multiple oncogenic activities of esophageal
cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol
Toxicol. 38:825–845. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Jin W, Wang L, Cheng S and Lv H:
Prognostic value of microRNA-378 in esophageal cancer and its
regulatory effect on tumor progression. Exp Ther Med. 22:7042021.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Kim S, Kim GH, Park SJ, Kwon CH, I H, Lee
MW and Lee BE: Exosomal MicroRNA analyses in esophageal squamous
cell carcinoma cell lines. J Clin Med. 11:44262022. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wen J, Wang G, Xie X, Lin G, Yang H, Luo
K, Liu Q, Ling Y, Xie X, Lin P, et al: Prognostic value of a
four-miRNA signature in patients with lymph node positive
locoregional esophageal squamous cell carcinoma undergoing complete
surgical resection. Ann Surg. 273:523–531. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Okuda Y, Shimura T, Iwasaki H, Fukusada S,
Nishigaki R, Kitagawa M, Katano T, Okamoto Y, Yamada T, Horike SI
and Kataoka H: Urinary microRNA biomarkers for detecting the
presence of esophageal cancer. Sci Rep. 11:85082021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Zhang J, Ling X, Fang C and Ma J:
Identification and validation of an eight-lncRNA signature that
predicts prognosis in patients with esophageal squamous cell
carcinoma. Cell Mol Biol Lett. 27:392022. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Cao S, Wang X, Liu X, Li J, Duan L, Gao Z,
Lun S, Zhu Y, Yang H, Zhang H and Zhou F: Integrative analysis of
angiogenesis-related long non-coding RNA and identification of a
six-DEARlncRNA signature associated with prognosis and therapeutic
response in esophageal squamous cell carcinoma. Cancers (Basel).
14:41952022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Liu Y, Wang L, Liu H, Li C and He J: The
prognostic significance of metabolic syndrome and a related
Six-lncRNA signature in esophageal squamous cell carcinoma. Front
Oncol. 10:612020. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Xie K, Zheng C, Gu W, Jiang Z, Luo C, Luo
J, Diao Y, Wang G, Cong Z, Yao X, et al: A RASSF8-AS1 based
exosomal lncRNAs panel used for diagnostic and prognostic
biomarkers for esophageal squamous cell carcinoma. Thorac Cancer.
13:3341–3352. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Huang E, Fu J, Yu Q, Xie P, Yang Z, Ji H,
Wang L, Luo G, Zhang Y and Li K: CircRNA hsa_circ_0004771 promotes
esophageal squamous cell cancer progression via miR-339-5p/CDC25A
axis. Epigenomics. 12:587–603. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Wang W, Zhu D, Zhao Z, Sun M, Wang F, Li
W, Zhang J and Jiang G: RNA sequencing reveals the expression
profiles of circRNA and identifies a four-circRNA signature acts as
a prognostic marker in esophageal squamous cell carcinoma. Cancer
Cell Int. 21:1512021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Hu X, Wu D, He X, Zhao H, He Z, Lin J,
Wang K, Wang W, Pan Z, Lin H and Wang M: circGSK3β promotes
metastasis in esophageal squamous cell carcinoma by augmenting
β-catenin signaling. Mol Cancer. 18:1602019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Bu J, Gu L, Liu X, Nan X, Zhang X, Meng L,
Zheng Y, Liu F, Li J, Li Z, et al: The circRNA circADAMTS6 promotes
progression of ESCC and correlates with prognosis. Sci Rep.
12:137572022. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Wang Q, Liu H, Liu Z, Yang L, Zhou J, Cao
X and Sun H: Circ-SLC7A5, a potential prognostic circulating
biomarker for detection of ESCC. Cancer Genet. 240:33–39. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Zhao Q, Zhu X, Ke JM, Su XY, Yi J, Wu DL,
Lin J and Deng ZQ: Circular RNA BMI1 serves as a potential target
for diagnosis and treatment in esophageal cancer. Technol Cancer
Res Treat. 20:153303382110330752021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Tang Y, Gao Z and Liu R: Identification
and function of circular RNA hsa_circ_0071106: A novel biomarker
for differentiation degree of esophageal squamous cell carcinoma.
Pathol Res Pract. 233:1538752022. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Chen B, Dragomir MP, Yang C, Li Q, Horst D
and Calin GA: Targeting non-coding RNAs to overcome cancer therapy
resistance. Signal Transduct Target Ther. 7:1212022. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Veneziano D, Di Bella S, Nigita G, Laganà
A, Ferro A and Croce CM: Noncoding RNA: Current deep sequencing
data analysis approaches and challenges. Hum Mutat. 37:1283–1298.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Anastasiadou E, Faggioni A, Trivedi P and
Slack F: The nefarious nexus of noncoding RNAs in cancer. Int J Mol
Sci. 19:20722018. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Nemeth K, Bayraktar R, Ferracin M and
Calin GA: Non-coding RNAs in disease: From mechanisms to
therapeutics. Nat Rev Genet. 25:211–232. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Sugihara H, Ishimoto T, Miyake K, Izumi D,
Baba Y, Yoshida N, Watanabe M and Baba H: Noncoding RNA expression
aberration is associated with cancer progression and is a potential
biomarker in esophageal squamous cell carcinoma. Int J Mol Sci.
16:27824–27834. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Li R, Chai L, Lei L, Guo R and Wen X:
MiR-671-5p sponging activity of circMMP1 promotes esophageal
squamous cancer progression. Thorac Cancer. 14:2924–2933. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Nan Y, Luo Q, Wu X, Chang W, Zhao P, Liu S
and Liu Z: HCP5 prevents ubiquitination-mediated UTP3 degradation
to inhibit apoptosis by activating c-Myc transcriptional activity.
Mol Ther. 31:552–568. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Qiao G, Zhang W and Dong K: Regulation of
ferroptosis by noncoding RNAs: A novel promise treatment in
esophageal squamous cell carcinoma. Mol Cell Biochem.
477:2193–2202. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Song W and Zou SB: Prognostic role of
lncRNA HOTAIR in esophageal squamous cell carcinoma. Clin Chim
Acta. 463:169–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Sang L, Yang L, Ge Q, Xie S, Zhou T and
Lin A: Subcellular distribution, localization, and function of
noncoding RNAs. Wiley Interdiscip Rev RNA. 13:e17292022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Shi X, Liu X, Pan S, Ke Y, Li Y, Guo W,
Wang Y, Ruan Q, Zhang X and Ma H: A novel autophagy-related long
non-coding RNA signature to predict prognosis and therapeutic
response in esophageal squamous cell carcinoma. Int J Gen Med.
14:8325–8339. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Zhu T, Ma Z, Wang H, Wei D, Wang B, Zhang
C, Fu L, Li Z and Yu G: Immune-related long non-coding RNA
signature and clinical nomogram to evaluate survival of patients
suffering esophageal squamous cell carcinoma. Front Cell Dev Biol.
9:6419602021. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Liao G, Tang J and Bai J: Early
development of esophageal squamous cell cancer: Stem cells,
cellular origins and early clone evolution. Cancer Lett.
555:2160472023. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Hu XY, Wang R, Jin J, Liu XJ, Cui AL, Sun
LQ, Li YP, Li Y, Wang YC, Zhen YS, et al: An EGFR-targeting
antibody-drug conjugate LR004-VC-MMAE: potential in esophageal
squamous cell carcinoma and other malignancies. Mol Oncol.
13:246–263. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Mimura K, Kono K, Maruyama T, Watanabe M,
Izawa S, Shiba S, Mizukami Y, Kawaguchi Y, Inoue M, Kono T, et al:
Lapatinib inhibits receptor phosphorylation and cell growth and
enhances antibody-dependent cellular cytotoxicity of EGFR- and
HER2-overexpressing esophageal cancer cell lines. Int J Cancer.
129:2408–2416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Meng L, Wu H, Wu J, Ding Pa, He J, Sang M
and Liu L: Mechanisms of immune checkpoint inhibitors: Insights
into the regulation of circular RNAS involved in cancer hallmarks.
Cell Death Dis. 15:32024. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Ding L, Lu S and Li Y: Regulation of
PD-1/PD-L1 pathway in cancer by noncoding RNAs. Pathol Oncol Res.
26:651–663. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Peng Y, Xu Y, Zhang X, Deng S, Yuan Y, Luo
X, Hossain MT, Zhu X, Du K, Hu F, et al: A novel protein
AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin
signaling pathway to promote gastric cancer progression. Mol
Cancer. 20:1582021. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z,
Xu B, Wu C, Zhou Q, Hu W, Wu C and Jiang J: A novel protein encoded
by a circular RNA circPPP1R12A promotes tumor pathogenesis and
metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer.
18:472019. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Imazeki H and Kato K: Development of
chemotherapeutics for unresectable advanced esophageal cancer.
Expert Rev Anticancer Ther. 20:1083–1092. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Fukuda T, Baba H, Okumura T, Kanda M,
Akashi T, Tanaka H, Miwa T, Watanabe T, Hirano K, Sekine S, et al:
miR-877-3p as a potential tumour suppressor of oesophageal squamous
cell carcinoma. Anticancer Res. 43:35–43. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Yu J, Chen S, Niu Y, Liu M, Zhang J, Yang
Z, Gao P, Wang W, Han X and Sun G: Functional significance and
therapeutic potential of miRNA-20b-5p in esophageal squamous cell
carcinoma. Mol Ther Nucleic Acids. 21:315–331. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Xing Y, Zha WJ, Li XM, Li H, Gao F, Ye T,
Du WQ and Liu YC: Circular RNA circ-Foxo3 inhibits esophageal
squamous cell cancer progression via the miR-23a/PTEN axis. J Cell
Biochem. 121:2595–2605. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Jin Y, Meng Q, Zhang B, Xie C, Chen X,
Tian B, Wang J, Shih TC, Zhang Y, Cao J, et al: Cancer-associated
fibroblasts-derived exosomal miR-3656 promotes the development and
progression of esophageal squamous cell carcinoma via the
ACAP2/PI3K-AKT signaling pathway. Int J Biol Sci. 17:3689–3701.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Shou Y, Wang X, Liang Y, Liu X and Chen K:
Exosomes-derived miR-154-5p attenuates esophageal squamous cell
carcinoma progression and angiogenesis by targeting kinesin family
member 14. Bioengineered. 13:4610–4620. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Yang J, Zhang Q, Zhao P, Qiao T, Cao Z,
Gao F, Liu M and Wu S: DNA methyltransferase 3 beta regulates
promoter methylation of microRNA-149 to augment esophageal squamous
cell carcinoma development through the ring finger protein
2/Wnt/β-catenin axis. Bioengineered. 13:4010–4027. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Yan J, Shi L, Lin S and Li Y:
MicroRNA-624-mediated ARRDC3/YAP/HIF1alpha axis enhances esophageal
squamous cell carcinoma cell resistance to cisplatin and
paclitaxel. Bioengineered. 12:5334–5347. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Suyal G, Pandey P, Saraya A and Sharma R:
Tumour suppressor role of microRNA-335-5p in esophageal squamous
cell carcinoma by targeting TTK (Mps1). Exp Mol Pathol.
124:1047382022. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Zhang L, Yu S, Yin X, Tu M, Cai L, Zhang
Y, Yu L, Zhang S, Pan X and Huang Y: MiR-942-5p inhibits tumor
migration and invasion through targeting CST1 in esophageal
squamous cell carcinoma. PLoS One. 18:e02770062023. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Wang J, Li J, Cheng D, Zhang K, Liu W, Xue
Q, Du R, Zhou L, Yeung YT, Bai R, et al: miR-132-3p promotes heat
stimulation-induced esophageal squamous cell carcinoma
tumorigenesis by targeting KCNK2. Mol Carcinog. 62:583–597. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Xu J, Wang J, Liu L, Chen L, Hu S and Liu
F: MicroRNA-196b is related to the overall survival of patients
with esophageal squamous cell carcinoma and facilitates tumor
progression by regulating SOCS2 (Suppressor Of Cytokine Signaling
2). Bioengineered. 12:7737–7746. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Xue J, Xiao P, Yu X and Zhang X: A
positive feedback loop between AlkB homolog 5 and miR-193a-3p
promotes growth and metastasis in esophageal squamous cell
carcinoma. Hum Cell. 34:502–514. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Li P, Liu X, Xing W, Qiu H, Li R, Liu S
and Sun H: Exosome-derived miR-200a promotes esophageal cancer cell
proliferation and migration via the mediating Keap1 expression. Mol
Cell Biochem. 477:1295–1308. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Luo XJ, He MM, Liu J, Zheng JB, Wu QN,
Chen YX, Meng Q, Luo KJ, Chen DL, Xu RH, et al: LncRNA TMPO-AS1
promotes esophageal squamous cell carcinoma progression by forming
biomolecular condensates with FUS and p300 to regulate TMPO
transcription. Exp Mol Med. 54:834–847. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Zhao Y, Zhang Q, Liu H, Wang N, Zhang X
and Yang S: lncRNA PART1, manipulated by transcriptional factor
FOXP2, suppresses proliferation and invasion in ESCC by regulating
the miR-18a-5p/SOX6 signaling axis. Oncol Rep. 45:1118–1132. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Tang J, Xu H, Liu Q, Zheng J, Pan C, Li Z,
Wen W, Wang J, Zhu Q, Wang Z and Chen L: LncRNA LOC146880 promotes
esophageal squamous cell carcinoma progression via
miR-328-5p/FSCN1/MAPK axis. Aging (Albany NY). 13:14198–14218.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Niu Y, Guo Y, Li Y, Shen S, Liang J, Guo W
and Dong Z: LncRNA GATA2-AS1 suppresses esophageal squamous cell
carcinoma progression via the mir-940/PTPN12 axis. Exp Cell Res.
416:1131302022. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Chen L, Lu J, Xu T, Yan Z, Guo Y, Dong Z
and Guo W: KTN1-AS1, a SOX2-mediated lncRNA, activates
epithelial-mesenchymal transition process in esophageal squamous
cell carcinoma. Sci Rep. 12:201862022. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Dong Z, Yang L, Lu J, Guo Y, Shen S, Liang
J and Guo W: Downregulation of LINC00886 facilitates
epithelial-mesenchymal transition through SIRT7/ELF3/miR-144
pathway in esophageal squamous cell carcinoma. Clin Exp Metastasis.
39:661–677. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Pan C, Chen G, Zhao X, Xu X and Liu J:
lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer
progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
Eur J Pharmacol. 934:1753172022. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Zhang H, Pan E, Zhang Y, Zhao C, Liu Q, Pu
Y and Yin L: LncRNA RPL34-AS1 suppresses the proliferation,
migration and invasion of esophageal squamous cell carcinoma via
targeting miR-575/ACAA2 axis. BMC Cancer. 22:10172022. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Lu JT, Yan ZY, Xu TX, Zhao F, Liu L, Li F
and Guo W: Reciprocal regulation of LINC00941 and SOX2 promotes
progression of esophageal squamous cell carcinoma. Cell Death Dis.
14:722023. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Fu X, Chen X, Si Y, Yao Y, Jiang Z and
Chen K: Long non-coding RNA NCK1-AS1 is overexpressed in esophageal
squamous cell carcinoma and predicts survival. Bioengineered.
13:8302–8310. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Wang C, Zhou M, Zhu P, Ju C, Sheng J, Du
D, Wan J, Yin H, Xing Y, Li H, et al: IGF2BP2-induced circRUNX1
facilitates the growth and metastasis of esophageal squamous cell
carcinoma through miR-449b-5p/FOXP3 axis. J Exp Clin Cancer Res.
41:3472022. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Song H, Tian D, Sun J, Mao X, Kong W, Xu
D, Ji Y, Qiu B, Zhan M and Wang J: circFAM120B functions as a tumor
suppressor in esophageal squamous cell carcinoma via the
miR-661/PPM1L axis and the PKR/p38 MAPK/EMT pathway. Cell Death
Dis. 13:3612022. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Guan X, Guan X, Wang Y, Lan T, Cheng T,
Cui Y and Xu H: Circ_0003340 downregulation mitigates esophageal
squamous cell carcinoma progression by targeting miR-940/PRKAA1
axis. Thorac Cancer. 13:1164–1175. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Liang W, Wang C, Wang J and Zhang M:
Hsa_circ_0023984 regulates cell proliferation, migration, and
invasion in esophageal squamous cancer via regulating
miR-1294/PI3K/Akt/c-Myc pathway. Appl Biochem Biotechnol. 194:1–16.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Qian CJ, Tong YY, Wang YC, Teng XS and Yao
J: Circ_0001093 promotes glutamine metabolism and cancer
progression of esophageal squamous cell carcinoma by targeting
miR-579-3p/glutaminase axis. J Bioenerg Biomembr. 54:119–134. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Tang R, Zhou Q, Xu Q, Lu L and Zhou Y:
Circular RNA circ_0006948 promotes esophageal squamous cell
carcinoma progression by regulating microRNA-3612/LASP1 axis. Dig
Dis Sci. 67:2158–2172. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Wang J, Li X, Duan C and Jia Y: CircFNDC3B
knockdown restrains the progression of oesophageal squamous cell
carcinoma through miR-214-3p/CDC25A axis. Clin Exp Pharmacol
Physiol. 49:1209–1220. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Sun Z, Zhang S, Zhang N, Wang J, Wang J
and Liu J: Circ_0005231 promotes the progression of esophageal
squamous cell carcinoma via sponging miR-383-5p and regulating
KIAA0101. Thorac Cancer. 13:1751–1762. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Wang YM, Zhao QW, Sun ZY, Lin HP, Xu X,
Cao M, Fu YJ, Zhao XJ, Ma XM and Ye Q: Circular RNA
hsa_circ_0003823 promotes the tumor progression, metastasis and
apatinib resistance of esophageal squamous cell carcinoma by
miR-607/CRISP3 axis. Int J Biol Sci. 18:5787–5808. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Meng F, Zhang X, Wang Y, Lin J, Tang Y,
Zhang G, Qiu B, Zeng X, Liu W and He X: Hsa_circ_0021727
(circ-CD44) promotes ESCC progression by targeting miR-23b-5p to
activate the TAB1/NFκB pathway. Cell Death Dis. 14:92023.
View Article : Google Scholar : PubMed/NCBI
|
